All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Cancer vaccines are pharmaceuticals designed to eliminate cancer cells by inducing an immune response, which can via either increasing antibody production or specific immune cell responses. Over time, vaccines have evolved from traditional antigen-based vaccines to cell-based vaccines and gene therapy-based vaccines. Creative Biolabs provides pre-clinical pharmacological services with scientific consideration of properties of cancer vaccines and their predictive clinical use.
Creative Biolabs supported the pre-clinical development of the following vaccines for decades with our unique range of products and professional services. Please visit here to find specific cancer vaccines.
Tumor Vaccines Under Development | ||
Conventional Antigen-based vaccines (Ag) | Cell-based vaccines | Gene therapy-based vaccines |
|
|
|
Creative Biolabs offers a wide range of modification services to optimize your candidate vaccines including adjuvants, immunomodulation, combination with conventional chemotherapy, formulations (liposomes), routes of administration (site and delivery device). We offer specific pharmacology studies in animal models to monitor specific biomarkers or endpoints via in vivo immunogenicity studies, challenge and protection studies, and testing of novel adjuvants and antigen delivery vectors. Our regulatory experts will ensure global regulations on quality and compliance are met, which can pave the way to market. Please visit the following buttons to learn how we can be involved in your pre-clinical pharmacology services.
To support tumor vaccine development, we established a full range of assays to evaluate various bioactivity endpoints including:
Various Bioactivity Endpoints |
|
We also provide 'Proof-of-Concept' models to understand the hypothetical mechanism of treatment and demonstrate "proof-of-efficacy" in an appropriate pre-clinical model.
Various Bioactivity Endpoints |
|
Our scientific, technical and regulatory experts provide the right expertise early in the pre-clinical development process to boost productivity, efficiency, and profitability and help our vaccine developers obtain the safest and most effective clinical vaccines. Creative Biolabs' unique combination of expertise in cancer immunology and preclinical pharmacology makes us an ideal partner to support your vaccine research. Please contact us to know more.
For any technical issues or product/service related questions, please leave your information below. Our team will contact you soon.
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION